Literature DB >> 3241460

Occurrence of rickettsiosis of spotted fever group in Chiba Prefecture of Japan.

I Kaiho1, M Tokieda, M Ohtawara, T Uchiyama, T Uchida.   

Abstract

Acute- and convalescent-phase sera were obtained from a patient with suspected tsutsugamushi disease in July 1987, in Amatsukominato located in the southeastern area of Chiba Prefecture, and showed negative serologic reactions with Rickettsia tsutsugamushi, while the convalescent-phase serum reacted positively with R. montana and a Japanese isolate of spotted fever group rickettsia at IgM and IgG titers of 1:320 and 1:640, respectively, in the indirect immunofluorescence test. These findings showed that a rickettsiosis of the spotted fever group occurred also in Chiba Prefecture like in the southeastern areas of Shikoku and Kyushu islands of Japan.

Entities:  

Mesh:

Year:  1988        PMID: 3241460     DOI: 10.7883/yoken1952.41.69

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  5 in total

1.  Species-specific monoclonal antibodies to Rickettsia japonica, a newly identified spotted fever group rickettsia.

Authors:  T Uchiyama; T Uchida; D H Walker
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 2.  Epidemiology of rickettsial diseases.

Authors:  D H Walker; D B Fishbein
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

Review 3.  Ecological questions concerning rickettsiae.

Authors:  J Rehácek; I V Tarasevich
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

4.  Important Clinical Features of Japanese Spotted Fever.

Authors:  Masamitsu Noguchi; Shizuka Oshita; Naohisa Yamazoe; Mitsukazu Miyazaki; Yousuke C Takemura
Journal:  Am J Trop Med Hyg       Date:  2018-06-28       Impact factor: 2.345

5.  Associations between Japanese spotted fever (JSF) cases and wildlife distribution on the Boso Peninsula, Central Japan (2006-2017).

Authors:  Hiroyuki Matsuyama; Masakatsu Taira; Maki Suzuki; Eiichiro Sando
Journal:  J Vet Med Sci       Date:  2020-10-02       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.